Risdiplam manufacturers
- Risdiplam
-
- $0.00 / 1Kg
-
2024-03-13
- CAS:1825352-65-5
- Min. Order: 1Kg
- Purity: 99.9%
- Supply Ability: 20tons
- Risdiplam
-
- $0.00 / 1g
-
2024-02-06
- CAS:1825352-65-5
- Min. Order: 1g
- Purity: 0.99
- Supply Ability: 100 kg
- Risdiplam
-
- $0.00 / 1kg
-
2023-10-09
- CAS:1825352-65-5
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 20tons
Related articles - How is Risdiplam synthesised?
- Risdiplam was approved by the USFDA for the treatment of spinal muscular atrophy caused by a mutation leading to a deficiency ....
- Dec 28，2023
|
| | Risdiplam Basic information |
| Product Name: | Risdiplam | | Synonyms: | 7-amino-2,3-dihydro-1H-inden-4-ol;Risdiplam;RO7034067;4H-Pyrido[1,2-a]pyrimidin-4-one, 7-(4,7-diazaspiro[2.5]oct-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-;Risdiplam (RG-7916, RO-7034067);RG7916;2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-7-(4,7-diazaspiro[2.5]octan-7-yl)-4H-pyrido[1,2-a]pyrimidin-4-one;2H4]-Risdiplam | | CAS: | 1825352-65-5 | | MF: | C22H23N7O | | MW: | 401.46 | | EINECS: | | | Product Categories: | | | Mol File: | 1825352-65-5.mol |  |
| | Risdiplam Chemical Properties |
| density | 1.50±0.1 g/cm3(Predicted) | | solubility | Soluble in DMSO | | pka | 9.41±0.20(Predicted) | | form | solid | | color | Light yellow to yellow | | InChI | InChI=1S/C22H23N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3 | | InChIKey | ASKZRYGFUPSJPN-UHFFFAOYSA-N | | SMILES | C12C=CC(N3CC4(CC4)NCC3)=CN1C(=O)C=C(C1=NN3C=C(C)N=C3C(C)=C1)N=2 |
| | Risdiplam Usage And Synthesis |
| Description | Risdiplam is a survival of motor neuron 2 (SMN2) splicing modifier. | | Chemical Properties | light yellow powder to yellow powder | | Uses | Risdiplam is used in preparation of Imidazopyridazinyl Pyridopyrimidinones for treating spinal muscular atrophy. Gene splicing modulator. | | Side effects | Body aches or pain, chest pain or tightness, chills, cough, ear congestion, fever, headache, loss of voice, runny or stuffy nose, sneezing, sore throat, trouble breathing, unusual tiredness or weakness and so on. | | storage | 0-4℃ for short term (days to weeks) or -20℃ for long term (months) |
| | Risdiplam Preparation Products And Raw materials |
|